What once curbed cravings might no longer be as effective
This means that members with government-sponsored insurance, those on a Kaiser plan, or those without insurance will need to consider one of the following options: (1) pay out of pocket for a GLP-1 medication or (2) if clinically eligible, use a non-GLP-1 medication that is included in the cost of a Weight Watchers Med+ membership
More receptors means more weight loss: 28.7% for retatrutide vs 22.5% for tirzepatide in trials, but also more side effects
Once reconstituted, that stability window shrinks to 28 days under refrigeration
While we anticipate retatrutide being a strong option for many people seeking weight loss, it may be particularly useful for anyone who falls into one or more of these categories: Didnt respond to earlier GLP-1 drugs like Wegovy, Ozempic, Rybelsus, Liraglutide, Zepbound, Mounjaro, etc Plateaued with other GLP-1s but still havent met your target weight Have a large body percentage of weight to lose (20% or more) Retatrutide is currently undergoing clinical trials necessary for it to obtain FDA approval (which is anticipated by summer) , so it's not yet available to be prescribed
A 30mL vial is standard and provides enough water for multiple reconstitutions
